Pharmaceuticals

The FDA defines Live Biotherapeutics as biological products that contain a live organism, such as a bacterium, that are useful in the prevention, treatment, or cure of a disease. 4D Pharma, founded in February 2014, is a global pioneer in the development of Live Biotherapeutics.

4SC is a creative biopharmaceutical firm with its headquarters in Planegg-Martinsried, close to Munich, Germany. It is heavily focused on oncology product development. For the treatment of cancer in indications with a high unmet medical need and great economic potential, we create innovative small molecule medicines.

Since more than 25 years ago, A&Z Pharmaceutical has been a pioneer in the development, production, and marketing of high-quality pharmaceutical goods and dietary supplements. Our products provide great nutritional value and educational guidance for the wellbeing of the entire family, encompassing life from newborns to active and ageing individuals.

Privately held, USFDA-approved, and one of the world's fastest-growing pharmaceutical companies, Aavis Pharmaceuticals is situated in the Atlanta region of the United States. The business manufactures and develops generic pharmaceuticals under contract.

Our objective is to offer protein research tools, technical assistance, and delivery that are of the highest calibre possible. a multinational corporation with the drive and ambition to become the most revered brand and impactful enterprise in the life sciences.

A biopharmaceutical business called Achilles Therapeutics is working on neoantigen-targeting T cell therapy. Neoantigens are protein markers that are unique to each person and are found on the surface of cancer cells, where they may be recognised by the immune system.

A wide-ranging pharmaceutical and fine chemical company, ACIC manufactures through a global network of partner production facilities that have undergone FDA inspection and adhere to cGMP standards. Active pharmaceutical ingredients (APIs), final dosage forms, injectables, contract manufacturing services, and more are all provided by ACIC to clients and partners.

We research, produce, and distribute new and well-established medications in fresh drug delivery modalities as a Swiss pharmaceutical firm with headquarters in Zurich. With an emphasis on modified release oral forms and oral dispersible forms, for which we also have patents, we are a pioneer in cutting-edge drug delivery technology.

The pharmaceutical business Adamas has experience in the discovery, creation, and delivery of drugs for the treatment of neurological illnesses. We are motivated by a strong sense of purpose: to radically improve day-to-day life for those with neurological illnesses.

A pharmaceutical firm in the clinical stages, Addex Therapeutics is dedicated to the creation and distribution of allosteric modulators, a novel class of orally accessible small molecules that are being developed to treat neurological illnesses.

Our goal is to develop medications of the highest calibre for the most reputable brands that are more readily available, more reasonably priced, and better than before. By influencing tomorrow's health, we want to improve the lives of millions of people around the world.

A speciality biopharmaceutical firm focused on areas of significant unmet medical need that is developing and commercialising a diverse portfolio of pharmacological and diagnostic products. The company's flagship product, macimorelin, is the first and only oral test for adult growth hormone insufficiency to be approved by the U.S. Food and Drug Administration and the European Commission (AGHD).